硒酵母对宫颈癌同步放化疗的近期疗效观察

杨梅; 裴波; 陈典

doi:10.7619/jcmp.20211191

硒酵母对宫颈癌同步放化疗的近期疗效观察

杨梅¹,
裴波²,
陈典^2, ,

1.
湖北民族大学医学部, 湖北恩施, 445000
2.
湖北民族大学附属恩施土家苗族自治州中心医院肿瘤科, 湖北恩施, 445000

基金项目:

湖北省恩施州科技项目 E20170002

详细信息

通讯作者:
陈典, E-mail: CD13986861928@163.com

中图分类号: R737.33;R453.9
计量
- 文章访问数: 294
- HTML全文浏览量: 156
- PDF下载量: 18
出版历程
- 收稿日期: 2021-03-18
- 网络出版日期: 2021-12-03
- 发布日期: 2021-11-27

Effect of selenium yeast on short-term efficacy in concurrent chemoradiotherapy for cervical cancer

1.
Medical College, Hubei Minzu University, Enshi, Hubei, 445000
2.
Oncology Department, the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture of Hubei Minzu University, Enshi, Hubei, 445000

摘要

摘要:
目的观察硒酵母片联合同步放化疗治疗ⅡB期宫颈癌患者的近期疗效。
方法纳入宫颈癌患者103例，将其随机分为对照组53例和实验组50例。实验组给予口服硒酵母片，对照组给予安慰剂，2组均给予含顺铂的同步放化疗方案。放疗结束后，通过实验室指标及影像学检查结果评估治疗前后病灶大小，骨髓抑制和肝、肾功能损伤程度。
结果 2组总有效率比较，差异有统计学意义（P < 0.05）。实验组与对照组骨髓抑制、肾损伤、肝损伤等毒副作用发生率比较，差异均无统计学意义（P>0.05）。
结论中晚期宫颈癌患者同步放化疗过程中服用硒酵母片的近期疗效优于单纯放化疗。
- 硒 /
- 宫颈癌 /
- 同步放化疗 /
- 近期疗效 /
- 毒副作用
Abstract:
Objective To observe the short-term efficacy of selenium yeast combined with concurrent chemoradiotherapy for patients with stage ⅡB cervical cancer.
Methods One hundred and three cervical cancer patients were included and randomly divided into experimental group (n=50) and control group (n=53). The experimental group was given oral selenium yeast, while control group was given placebo, and both groups received concurrent chemoradiotherapy with cisplatin. After radiotherapy, the tumor lesion, myelosuppression, liver and kidney impairment were assessed by laboratory indicators and imaging results.
Results There were statistically significant difference in total effective rate between the two groups (P < 0.05). There was no significant difference in the incidence of bone marrow suppression, kidney injury, liver injury and other toxic and side effects between the experimental group and the control group (P>0.05).
Conclusion The short-term efficacy of selenium yeast tablets during concurrent chemoradiotherapy in patients with advanced cervical cancer is better than that of chemoradiotherapy alone.
- selenium /
- cervical cancer /
- concurrent chemoradiotherapy /
- short-term efficacy /
- toxic and side effects

HTML全文

表 1 2组毒性反应分级比较[n(%)]

毒性反应	实验组(n=50)				对照组(n=53)
毒性反应	Ⅰ度	Ⅱ度	Ⅲ度	Ⅳ度	Ⅰ度	Ⅱ度	Ⅲ度	Ⅳ度
骨髓抑制	8(16.00)	25(50.00)	15(30.00)	2(3.77)	8(15.09)	21(39.62)	18(33.96)	4(7.55)
肝功能异常	30(60.00)	7(14.00)	0	0	23(43.40)	4(7.55)	1(1.89)	1(1.89)
肾功能异常	9(18.00)	0	0	0	5(9.43)	2(3.77)	0	0

下载: 导出CSV

参考文献(17)

[1]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
[2]	王颖杰, 朱启峰, 陈友山. 同步放化疗与序贯放化疗法治疗局部晚期非小细胞肺癌的近期疗效和不良反应比较[J]. 当代医学, 2021, 27(4): 79-81. doi: 10.3969/j.issn.1009-4393.2021.04.031
[3]	郝敏, 张娜. 宫颈癌新辅助化疗与同步放化疗[J]. 中国实用妇科与产科, 2010, 26(3): 168-174. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201003007.htm
[4]	LIU Y, LI W, GUO M, et al. Protective role of selenium compounds on the proliferation, apoptosis, and angiogenesis of a canine breast cancer cell line[J]. Biological Trace Element Research, 2016, 169(1): 86-93. doi: 10.1007/s12011-015-0387-3
[5]	向芳, 李胜, 郝莲, 等. 2003-2017年中国女性宫颈癌死亡率趋势分析[J]. 卫生经济研究, 2020, 37(5): 23-27.
[6]	敖梅红, 邓旭情, 熊艳, 等. 7 051例宫颈癌患者发病趋势分析[J]. 现代妇产科进展, 2018, 27(1): 48-50. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201801012.htm
[7]	熊慧, 刘平, 邹文, 等. 局部中晚期宫颈癌同步放化疗临床疗效及预后影响因素分析[J]. 中国全科医学, 2018, 21(17): 2053-2058. doi: 10.3969/j.issn.1007-9572.2017.00.235
[8]	LOBB R J, JACOBSON G M, CURSONS R T, et al. The interaction of selenium with chemotherapy and radiation on normal and malignant human mononuclear blood cells[J]. International Journal of Molecular Sciences, 2018, 19(10): 1-12. http://www.onacademic.com/detail/journal_1000040888411810_d053.html
[9]	BAS E, NAZIROGLU M. Selenium attenuates docetaxel-induced apoptosis and mitochondrial oxidative stress in kidney cells[J]. Anti-Cancer Drugs, 2019, 30(4): 339-346. doi: 10.1097/CAD.0000000000000723
[10]	LUBINSKI J, MARCINIAK W, MUSZYNSKA M, et al. Serum selenium levels predict survival after breast cancer[J]. Breast Cancer Res Treat, 2018, 167(2): 591-598. doi: 10.1007/s10549-017-4525-9
[11]	SOUMYA M, SHRUDHI D, SANTHIYA R, et al. Selenium nanoparticles a potent chemotherapeutic agent and an elucidation of its mechanism[J]. Colloids and Surfaces B: Biointerfaces, 2018, 170: 280-292. doi: 10.1016/j.colsurfb.2018.06.006
[12]	GUO C H, HSIA S, SHIH M Y, et al. Effects of selenium yeast on oxidative stress, growth inhibition, and apoptosis in human breast cancer cells[J]. Int J Med Sci, 2015, 12(9): 748-758. doi: 10.7150/ijms.12177
[13]	QIAN S, XIE L X, LI G B, et al. Radiosensitization effect of selenocystine on HeLa cells in vitro[J]. Precision Radiation Oncology, 2020, 4(1): 4-9. doi: 10.1002/pro6.1085
[14]	FRANCA CAS, NOGUEIRA C R, RAMALHO A, et al. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy[J]. Annals of Oncology, 2011, 22(5): 1109-1112. doi: 10.1093/annonc/mdq547
[15]	林显敢, 谢德荣, 梁新文, 等. 硒制剂在预防化疗过程中血液毒性的作用[J]. 微量元素与健康研究, 2001, 18(2): 23-24. https://www.cnki.com.cn/Article/CJFDTOTAL-WYJK200102010.htm
[16]	SIEJA K, TALERCZYK M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy[J]. Gynecologic Oncology, 2004, 93(2): 320-327. doi: 10.1016/j.ygyno.2003.12.013
[17]	DUFFIELD-LILLICO A J, DALKIN B L, REID M E, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial[J]. BJU International, 2003, 91(7): 608-612. doi: 10.1046/j.1464-410X.2003.04167.x